enGene Therapeutics Inc. – Credit Agreements

NASDAQ: ENGN
Share price (7/7/26): $1.92
Market cap (7/7/26): $129 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Credit Agreements Filter

from 8-K 84 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Second Amendment to Amended & Restated Loan and Security Agreement

from 10-K 10 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. First Amendment to Amended and Restated Loan and Security Agreement

from 8-K 61 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Amended and Restated Loan and Security Agreement